Literature DB >> 2475845

Antibody to carbohydrate and polypeptide epitopes on the surface of schistosomula of Schistosoma mansoni in Egyptian patients with acute and chronic schistosomiasis.

P Omer Ali1, M Mansour, J N Woody, S R Smithers, A J Simpson.   

Abstract

125I-Schistosoma mansoni schistosomulum surface antigens were immunoprecipitated with human antibodies from individual Egyptian patients diagnosed as being either acutely or chronically infected with S. mansoni. Both sets of patients were found to have IgG antibodies in their sera capable of immunoprecipitating the major Mr greater than 200, 38 and 32K antigens. However, the immunoprecipitation of the Mr greater than 200K antigen was found to constitute a significantly greater proportion of the total precipitate achieved with acute sera than with chronic sera. The Mr 38 and 32K antigens were more variably precipitated by the acute sera than the chronic sera but the proportion of the total precipitation that these two antigens constituted was not found to be significantly different between the two sets of sera. Immunoprecipitation with pooled antibodies absorbed with egg and adult worm homogenates which had been treated to remove either carbohydrate or polypeptide epitopes demonstrated that the Mr greater than 200K antigen was the principal target of egg-cross-reactive anti-carbohydrate antibody amongst the antigens detected. The Mr 38 and 32K antigens were found to be precipitated by antibodies to protease-sensitive and periodate-insensitive polypeptide epitopes. These results are consistent with egg-cross-reactive anti-carbohydrate IgG antibody making a greater contribution to schistosomulum surface recognition in acute infection than in chronic infection. Indeed the presence of a higher level of egg-cross-reactive and anti-carbohydrate antibody directed against schistosomulum surface epitopes in an acute serum pool than in a chronic serum pool was confirmed by measurement of antibody binding to whole schistosomula.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475845     DOI: 10.1017/s0031182000061503

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  5 in total

1.  Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees.

Authors:  M Eberl; J A Langermans; P A Frost; R A Vervenne; G J van Dam; A M Deelder; A W Thomas; P S Coulson; R A Wilson
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Specific antibody responses to three schistosome-related carbohydrate structures in recently exposed immigrants and established residents in an area of Schistosoma mansoni endemicity.

Authors:  Cynthia W A Naus; Alexandra van Remoortere; John H Ouma; Gachuhi Kimani; David W Dunne; Johannis P Kamerling; André M Deelder; Cornelis H Hokke
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.

Authors:  Nina Salinger Prasanphanich; Anthony E Luyai; Xuezheng Song; Jamie Heimburg-Molinaro; Msano Mandalasi; Megan Mickum; David F Smith; A Kwame Nyame; Richard D Cummings
Journal:  Glycobiology       Date:  2014-04-11       Impact factor: 4.313

Review 4.  Glycoconjugates in host-helminth interactions.

Authors:  Nina Salinger Prasanphanich; Megan L Mickum; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Immunol       Date:  2013-08-28       Impact factor: 7.561

Review 5.  Deciphering the glycogenome of schistosomes.

Authors:  Megan L Mickum; Nina S Prasanphanich; Jamie Heimburg-Molinaro; Kristoffer E Leon; Richard D Cummings
Journal:  Front Genet       Date:  2014-08-05       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.